bioRASI Names David Judson Vice President, Chief Compliance Officer

AVENTURA, FL--(Marketwire - June 14, 2012) -

bioRASI, a full service, global Contract Research Organization (CRO), announced today that David Judson has joined the company as Vice President and Chief Compliance Officer. bioRASI is continuing significant expansion of its worldwide operations and is further strengthening its centralized Compliance, QA, Audit and Training infrastructure. David Judson will lead these efforts.

“We are extremely pleased to bring David Judson to lead our Compliance and Audit services branch,” said Dr. Boris Reznik, Chairman of bioRASI. “Our acquaintance with David started six years ago when he conducted a sponsor audit of bioRASI. From the very beginning it was clear that we share similar views on the role and importance of quality functions at a CRO. This resonance has been a great foundation of our long term relations with David. As bioRASI’s quality infrastructure has expanded, it became essential to add the compliance officer of David’s caliber to our team.”

Prior to joining bioRASI, David Judson has spent over 25 years in leading compliance functions at big and small Pharma as well as CROs. The breadth of Mr. Judson’s quality focused experience covers R&D discovery, pre-clinical (GLP), Phase I-IV (GCP), clinical packaging, and pharmaceutical manufacturing (GMP and ISO 9000). He has conducted more than 1500 audits in over 25 countries and 49 US states. David holds BS and MA degrees in chemistry from the University of South Dakota.

“I am very excited about joining the bioRASI team and working with some of the most dedicated, knowledgeable and accomplished professionals in the industry,” said David Judson. “bioRASI’s outstanding quality has already been recognized through various awards and achievements in the industry. I am looking forward to continuing to build bioRASI’s industry leadership position in the compliance and quality areas.”

About bioRASI
bioRASI is an award-winning Full Service Global CRO providing clinical development services that optimize its sponsors’ scientific, clinical, and business results. bioRASI facilitates obtaining drugs, biotherapeutics, and medical devices marketing approvals by delivering high quality regulatory and clinical strategies, solutions and services. The Company’s unique access to the largest facilities and patient populations all over the world saves their clients critical time. bioRASI’s services include program optimization, project management, regulatory, clinical, data management and analysis, compliance and audit. bioRASI is headquartered in Aventura, FL and has regional offices and operations across North America and around the world.